Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 10.43
+0.29 (2.86%)
Aug 20, 2026, 3:00 PM CST
SHA:603998 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 219.24 | 276.25 | 308.46 | 208.98 | 399.72 | 258.88 |
Trading Asset Securities | 35 | - | - | 20.33 | 40.31 | 15.42 |
Cash & Short-Term Investments | 254.24 | 276.25 | 308.46 | 229.3 | 440.03 | 274.3 |
Cash Growth | 35.79% | -10.44% | 34.52% | -47.89% | 60.42% | -14.05% |
Accounts Receivable | 269.09 | 267.15 | 285.32 | 231.09 | 191.95 | 254.67 |
Other Receivables | 34.73 | 32.53 | 37.87 | 13.5 | 164.9 | 30.2 |
Receivables | 325.54 | 321.41 | 376.59 | 244.59 | 356.85 | 284.87 |
Inventory | 350.59 | 338.71 | 376.15 | 328.28 | 303.4 | 256.73 |
Other Current Assets | 82.89 | 77.47 | 76.34 | 118.49 | 90.81 | 50.74 |
Total Current Assets | 1,013 | 1,014 | 1,138 | 920.67 | 1,191 | 866.63 |
Property, Plant & Equipment | 1,140 | 1,143 | 1,110 | 1,051 | 841.25 | 823.03 |
Long-Term Investments | 158.29 | 158.01 | 239.1 | 257.52 | 252.97 | 193.91 |
Goodwill | 265.21 | 265.21 | 269.03 | 274.41 | 246.44 | 378.73 |
Other Intangible Assets | 254.51 | 251.13 | 281.59 | 267.68 | 273.71 | 249.95 |
Long-Term Accounts Receivable | - | - | - | - | 26.38 | 42.39 |
Long-Term Deferred Tax Assets | 10.92 | 11.27 | 10.15 | 15.6 | 4.24 | 1.53 |
Long-Term Deferred Charges | 18.45 | 16.31 | 13.77 | 18.13 | 8.06 | 41.09 |
Other Long-Term Assets | 167.75 | 168.51 | 158.31 | 126.44 | 78.27 | 107.21 |
Total Assets | 3,056 | 3,056 | 3,267 | 3,081 | 2,922 | 2,704 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 163.87 | 170.62 | 244.26 | 245.82 | 165.61 | 117.18 |
Accrued Expenses | 27.6 | 376.15 | 319.76 | 294.96 | 311.88 | 272.16 |
Short-Term Debt | 358.45 | 343.63 | 531.49 | 309.27 | 229.96 | 462.95 |
Current Portion of Long-Term Debt | 25.65 | 59.99 | 1.1 | 193.88 | 20.11 | 13.85 |
Current Portion of Leases | - | 5.7 | 2.02 | 2.35 | 0.49 | 10.46 |
Current Income Taxes Payable | 38.84 | 28.19 | 3.89 | 10.05 | 25.06 | 9.89 |
Current Unearned Revenue | 31.94 | 33.97 | 36.22 | 38.98 | 87.47 | 35.1 |
Other Current Liabilities | 473.89 | 132.2 | 159.79 | 152.77 | 159.02 | 333.87 |
Total Current Liabilities | 1,120 | 1,150 | 1,299 | 1,248 | 999.59 | 1,255 |
Long-Term Debt | - | - | 146.5 | 155.11 | 342.89 | 27.75 |
Long-Term Leases | 21.14 | 22.72 | 19.04 | 21.31 | 0.84 | 37.04 |
Long-Term Unearned Revenue | 43.95 | 44.06 | 34.06 | 32.86 | 37.22 | 53.41 |
Long-Term Deferred Tax Liabilities | 31.43 | 32.1 | 33.57 | 34.51 | 33.92 | 27.17 |
Other Long-Term Liabilities | 3.35 | 3.62 | - | 0.38 | - | - |
Total Liabilities | 1,220 | 1,253 | 1,532 | 1,492 | 1,414 | 1,401 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 439.08 | 439.08 | 439.09 | 439.73 | 439.31 | 429.43 |
Additional Paid-In Capital | 151.1 | 151.1 | 189.63 | 185.82 | 163.87 | 131.93 |
Retained Earnings | 1,144 | 1,122 | 995.33 | 849.61 | 816.65 | 634.76 |
Treasury Stock | - | - | -1 | -17 | -29.63 | - |
Comprehensive Income & Other | -0.39 | -0.2 | -0.07 | -0.07 | -0.07 | -0.07 |
Total Common Equity | 1,734 | 1,712 | 1,623 | 1,458 | 1,390 | 1,196 |
Minority Interest | 101.39 | 91.15 | 111.9 | 130.63 | 117.81 | 107.6 |
Shareholders' Equity | 1,835 | 1,803 | 1,735 | 1,589 | 1,508 | 1,304 |
Total Liabilities & Equity | 3,056 | 3,056 | 3,267 | 3,081 | 2,922 | 2,704 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 405.24 | 432.03 | 700.15 | 681.93 | 594.3 | 552.05 |
Net Cash (Debt) | -151 | -155.78 | -391.69 | -452.62 | -154.26 | -277.75 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.34 | -0.36 | -0.89 | -1.02 | -0.36 | -0.63 |
Filing Date Shares Outstanding | 439.08 | 439.08 | 439.09 | 439.73 | 439.31 | 429.43 |
Total Common Shares Outstanding | 439.08 | 439.08 | 439.09 | 439.73 | 439.31 | 429.43 |
Working Capital | -106.97 | -136.61 | -160.99 | -327.42 | 191.5 | -388.83 |
Book Value Per Share | 3.95 | 3.90 | 3.70 | 3.32 | 3.16 | 2.79 |
Tangible Book Value | 1,214 | 1,195 | 1,072 | 916.01 | 869.98 | 567.36 |
Tangible Book Value Per Share | 2.77 | 2.72 | 2.44 | 2.08 | 1.98 | 1.32 |
Buildings | - | 995.38 | 801.14 | 774.18 | 635.14 | 529.35 |
Machinery | - | 482.97 | 421.59 | 384.19 | 309.4 | 362.11 |
Construction In Progress | - | 83.58 | 262.36 | 217.53 | 189.65 | 201.99 |